$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 9, 2025)
$852.21M
Market Cap
-
P/E Ratio
-3.94
EPS
$17.28
52 Week High
$7.30
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
KalVista Pharmaceuticals Inc, based in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company that specializes in the discovery and development of small-molecule protease inhibitors to address significant unmet medical needs. The firm is particularly focused on therapeutic areas including hereditary angioedema and diabetic macular edema, leveraging its proprietary drug development platform to foster the creation of targeted therapies. With a robust pipeline and strategic partnerships, KalVista is poised to drive innovation in the pharmaceutical landscape, demonstrating a strong commitment to improving patient outcomes through advanced scientific research and development.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG